December 12, 2018 Press release - Regulatory Targovax Presents at DNB 9th Annual Nordic Healthcare Conference
September 12, 2018 Press release - Regulatory Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy
September 4, 2018 Press release - Regulatory Targovax ASA: Registration of new share capital following settlement of restricted stock units
August 29, 2018 Press release - Regulatory Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
August 15, 2018 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
June 20, 2018 Press release - Regulatory Targovax ASA: Mandatory notification of trade – primary insider
June 4, 2018 Press release - Regulatory Targovax to Present at Jefferies 2018 Global Healthcare Conference
May 16, 2018 Press release - Regulatory Targovax to present at upcoming investor and industry conferences
April 25, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
April 24, 2018 Press release - Regulatory Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
March 24, 2018 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018
March 1, 2018 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors
February 6, 2018 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
November 3, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
October 27, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
October 24, 2017 Press release - Regulatory Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November
September 12, 2017 Press release - Regulatory Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies
August 29, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
August 28, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
August 25, 2017 Press release - Regulatory Exercise of employee share options and restricted stock units in Targovax ASA
August 18, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 14, 2017 Press release - Regulatory Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
July 14, 2017 Press release - Regulatory Targovax ASA: Last day of the subscription period in the subsequent offering
July 6, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following the private placement
July 3, 2017 Press release - Regulatory Targovax ASA: Commencement of subscription period for the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Approval and publication of prospectus; the subsequent offering
June 30, 2017 Press release - Regulatory Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering
June 26, 2017 Press release - Regulatory Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units
June 22, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options
June 22, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA
June 15, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units
June 14, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
June 9, 2017 Press release - Regulatory Targovax ASA – Information on the subsequent offering – Key date information
June 6, 2017 Press release - Regulatory Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London
May 8, 2017 Press release - Regulatory Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017
April 28, 2017 Press release - Regulatory Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members
April 19, 2017 Press release - Regulatory Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April
April 4, 2017 Press release - Regulatory Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017
February 24, 2017 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
February 24, 2017 Press release - Regulatory Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
February 13, 2017 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units
February 10, 2017 Press release - Regulatory Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
February 6, 2017 Press release - Regulatory Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
November 21, 2016 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options
November 21, 2016 Press release - Regulatory Targovax ASA: Exercise of employee share options in Targovax ASA
November 18, 2016 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider
November 8, 2016 Press release - Regulatory Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November
November 4, 2016 Press release - Regulatory Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 15, 2016 Press release - Regulatory Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August
July 1, 2016 Press release - Regulatory Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma
June 9, 2016 Press release - Regulatory Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102
June 7, 2016 Press release - Regulatory Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed
June 2, 2016 Press release - Regulatory Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations
May 9, 2016 Press release - Regulatory Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016
April 14, 2016 Press release - Regulatory Targovax reports immune response with reduced number of TG01 vaccinations
March 14, 2016 Press release - Regulatory Targovax to present at forthcoming Life Science and Investor conferences
March 10, 2016 Press release - Regulatory Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer
February 25, 2016 Press release - Regulatory CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 25, 2016 Press release - Regulatory Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 2, 2016 Press release - Regulatory Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain
November 19, 2015 Press release - Regulatory Targovax ASA: Invitation to presentation of Targovax’ third quarter 2015 results
November 18, 2015 Press release - Regulatory Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS
November 5, 2015 Press release - Regulatory Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors